Stage Ingénieur 6 mois F/H at Eli Lilly and Company

Fegersheim, Grand Est, France

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Ingénieur généraliste (4ème ou 5ème année)
Maîtrise de l’anglais indispensable
Bonnes qualités relationnelles
Esprit analytique et créatif
Curiosité technique afin de rechercher des solutions innovantes
Bonne communication orale et écrite

Responsibilities

Réalisation d’une étude « business case » : définition de la problématique et de la solution, du project charter, coût et retour sur investissement
Rédaction cahier des charges
Étude de faisabilité technique : choix des puces RFID adaptées aux environnements de lavage/autoclavage, positionnement optimal sur les pièces
Conception d’une interface intuitive pour le suivi et l’assistance au montage
Définition des seuils d’alerte pour la maintenance préventive
Participation à des tests terrain et à l’analyse des données collectées

Skills

RFID

RFID Technology

Industrial Automation

Real-time Tracking

Data Monitoring

Traceability Systems

Autoclave Monitoring

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free